Myriam M. Chaumeil, PhD, is an Associate Professor in Residence in the departments of Physical Therapy & Rehabilitation Science, and Radiology & Biomedical Imaging at the University of California, San Francisco (UCSF). She is also a research group leader in Metabolic Imaging of Neurological disorders, a core member of the UCSF/UC Berkeley BioEngineering Graduate Program, a core member of the UCSF Biomedical Science Graduate program, a core member of the UCSF PhD in Rehabilitation Science Graduate Program, and a faculty member of the California Institute for Quantitative Biosciences (QBI).

Dr. Chaumeil's research focuses on developing and validating magnetic resonance (MR)-based imaging and spectroscopy methods for in vivo measurement of brain metabolism, in physiological and pathological conditions, in preclinical models and in patients. She has experience in studies of Huntington’s disease, Multiple Sclerosis, Alzheimer’s disease, Traumatic Brain Injury, cerebral small vascular diseases and CNS lymphoma. She has extensive internationally recognized expertise in MR metabolic imaging, particularly in state-of-the-art hyperpolarized 13C MRS method, and has a particular interest in expanding the use of this MR metabolic imaging method to the study of neurodegeneration with an ultimate goal of clinical translation.

Dr. Chaumeil concurrently obtained a Engineer Diploma - Physics Major - from the Ecole Superieure de Physique et Chimie Industrielles de Paris (EPSCI) and a Master in Medical Imaging from the University of Paris XI/Orsay. She then received her PhD in medical imaging for her graduate work on developing innovative MR spectroscopy approaches for the study of brain metabolism. She completed a postdoctoral fellowship at UCSF before joining the faculty in 2016.